Global Hospital-acquired infections (HAIs) Control Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Hospital-acquired infections (HAIs) Control market size was valued at USD 5867.2 million in 2023 and is forecast to a readjusted size of USD 7101.9 million by 2030 with a CAGR of 2.8% during review period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Hospital-acquired infections (HAIs) Control industry chain, the market status of General Hospital (Diagnostic techniques, Dleaning and sterilization), Infectious Disease Hospital (Diagnostic techniques, Dleaning and sterilization), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hospital-acquired infections (HAIs) Control.
Regionally, the report analyzes the Hospital-acquired infections (HAIs) Control markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hospital-acquired infections (HAIs) Control market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hospital-acquired infections (HAIs) Control market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hospital-acquired infections (HAIs) Control industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Diagnostic techniques, Dleaning and sterilization).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hospital-acquired infections (HAIs) Control market.
Regional Analysis: The report involves examining the Hospital-acquired infections (HAIs) Control market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hospital-acquired infections (HAIs) Control market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hospital-acquired infections (HAIs) Control:
Company Analysis: Report covers individual Hospital-acquired infections (HAIs) Control players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hospital-acquired infections (HAIs) Control This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (General Hospital, Infectious Disease Hospital).
Technology Analysis: Report covers specific technologies relevant to Hospital-acquired infections (HAIs) Control. It assesses the current state, advancements, and potential future developments in Hospital-acquired infections (HAIs) Control areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hospital-acquired infections (HAIs) Control market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hospital-acquired infections (HAIs) Control market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Hospital-acquired infections (HAIs) Control product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital-acquired infections (HAIs) Control, with revenue, gross margin and global market share of Hospital-acquired infections (HAIs) Control from 2019 to 2024.
Chapter 3, the Hospital-acquired infections (HAIs) Control competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hospital-acquired infections (HAIs) Control market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-acquired infections (HAIs) Control.
Chapter 13, to describe Hospital-acquired infections (HAIs) Control research findings and conclusion.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Hospital-acquired infections (HAIs) Control industry chain, the market status of General Hospital (Diagnostic techniques, Dleaning and sterilization), Infectious Disease Hospital (Diagnostic techniques, Dleaning and sterilization), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hospital-acquired infections (HAIs) Control.
Regionally, the report analyzes the Hospital-acquired infections (HAIs) Control markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hospital-acquired infections (HAIs) Control market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Hospital-acquired infections (HAIs) Control market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hospital-acquired infections (HAIs) Control industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Diagnostic techniques, Dleaning and sterilization).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hospital-acquired infections (HAIs) Control market.
Regional Analysis: The report involves examining the Hospital-acquired infections (HAIs) Control market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hospital-acquired infections (HAIs) Control market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Hospital-acquired infections (HAIs) Control:
Company Analysis: Report covers individual Hospital-acquired infections (HAIs) Control players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hospital-acquired infections (HAIs) Control This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (General Hospital, Infectious Disease Hospital).
Technology Analysis: Report covers specific technologies relevant to Hospital-acquired infections (HAIs) Control. It assesses the current state, advancements, and potential future developments in Hospital-acquired infections (HAIs) Control areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hospital-acquired infections (HAIs) Control market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Hospital-acquired infections (HAIs) Control market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Diagnostic techniques
- Dleaning and sterilization
- Treatment
- General Hospital
- Infectious Disease Hospital
- STERIS Corporation
- Advanced Sterilization Products Division
- Hoffmann-La Roche
- Pfizer
- Becton Dickinson
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Hospital-acquired infections (HAIs) Control product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Hospital-acquired infections (HAIs) Control, with revenue, gross margin and global market share of Hospital-acquired infections (HAIs) Control from 2019 to 2024.
Chapter 3, the Hospital-acquired infections (HAIs) Control competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Hospital-acquired infections (HAIs) Control market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Hospital-acquired infections (HAIs) Control.
Chapter 13, to describe Hospital-acquired infections (HAIs) Control research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Hospital-acquired infections (HAIs) Control
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital-acquired infections (HAIs) Control by Type
1.3.1 Overview: Global Hospital-acquired infections (HAIs) Control Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type in 2023
1.3.3 Diagnostic techniques
1.3.4 Dleaning and sterilization
1.3.5 Treatment
1.4 Global Hospital-acquired infections (HAIs) Control Market by Application
1.4.1 Overview: Global Hospital-acquired infections (HAIs) Control Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 General Hospital
1.4.3 Infectious Disease Hospital
1.5 Global Hospital-acquired infections (HAIs) Control Market Size & Forecast
1.6 Global Hospital-acquired infections (HAIs) Control Market Size and Forecast by Region
1.6.1 Global Hospital-acquired infections (HAIs) Control Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Hospital-acquired infections (HAIs) Control Market Size by Region, (2019-2030)
1.6.3 North America Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
1.6.4 Europe Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
1.6.6 South America Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 STERIS Corporation
2.1.1 STERIS Corporation Details
2.1.2 STERIS Corporation Major Business
2.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Product and Solutions
2.1.4 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 STERIS Corporation Recent Developments and Future Plans
2.2 Advanced Sterilization Products Division
2.2.1 Advanced Sterilization Products Division Details
2.2.2 Advanced Sterilization Products Division Major Business
2.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product and Solutions
2.2.4 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Advanced Sterilization Products Division Recent Developments and Future Plans
2.3 Hoffmann-La Roche
2.3.1 Hoffmann-La Roche Details
2.3.2 Hoffmann-La Roche Major Business
2.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product and Solutions
2.3.4 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Hoffmann-La Roche Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Hospital-acquired infections (HAIs) Control Product and Solutions
2.4.4 Pfizer Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Becton Dickinson
2.5.1 Becton Dickinson Details
2.5.2 Becton Dickinson Major Business
2.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Product and Solutions
2.5.4 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Becton Dickinson Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hospital-acquired infections (HAIs) Control Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Hospital-acquired infections (HAIs) Control by Company Revenue
3.2.2 Top 3 Hospital-acquired infections (HAIs) Control Players Market Share in 2023
3.2.3 Top 6 Hospital-acquired infections (HAIs) Control Players Market Share in 2023
3.3 Hospital-acquired infections (HAIs) Control Market: Overall Company Footprint Analysis
3.3.1 Hospital-acquired infections (HAIs) Control Market: Region Footprint
3.3.2 Hospital-acquired infections (HAIs) Control Market: Company Product Type Footprint
3.3.3 Hospital-acquired infections (HAIs) Control Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hospital-acquired infections (HAIs) Control Consumption Value and Market Share by Type (2019-2024)
4.2 Global Hospital-acquired infections (HAIs) Control Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2024)
5.2 Global Hospital-acquired infections (HAIs) Control Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
6.2 North America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
6.3 North America Hospital-acquired infections (HAIs) Control Market Size by Country
6.3.1 North America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2030)
6.3.2 United States Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
6.3.3 Canada Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
6.3.4 Mexico Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
7.2 Europe Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
7.3 Europe Hospital-acquired infections (HAIs) Control Market Size by Country
7.3.1 Europe Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2030)
7.3.2 Germany Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7.3.3 France Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7.3.5 Russia Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7.3.6 Italy Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Region
8.3.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Region (2019-2030)
8.3.2 China Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.3 Japan Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.4 South Korea Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.5 India Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.7 Australia Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
9.2 South America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
9.3 South America Hospital-acquired infections (HAIs) Control Market Size by Country
9.3.1 South America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2030)
9.3.2 Brazil Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
9.3.3 Argentina Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country
10.3.1 Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2030)
10.3.2 Turkey Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
10.3.4 UAE Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Hospital-acquired infections (HAIs) Control Market Drivers
11.2 Hospital-acquired infections (HAIs) Control Market Restraints
11.3 Hospital-acquired infections (HAIs) Control Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hospital-acquired infections (HAIs) Control Industry Chain
12.2 Hospital-acquired infections (HAIs) Control Upstream Analysis
12.3 Hospital-acquired infections (HAIs) Control Midstream Analysis
12.4 Hospital-acquired infections (HAIs) Control Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Hospital-acquired infections (HAIs) Control
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Hospital-acquired infections (HAIs) Control by Type
1.3.1 Overview: Global Hospital-acquired infections (HAIs) Control Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type in 2023
1.3.3 Diagnostic techniques
1.3.4 Dleaning and sterilization
1.3.5 Treatment
1.4 Global Hospital-acquired infections (HAIs) Control Market by Application
1.4.1 Overview: Global Hospital-acquired infections (HAIs) Control Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 General Hospital
1.4.3 Infectious Disease Hospital
1.5 Global Hospital-acquired infections (HAIs) Control Market Size & Forecast
1.6 Global Hospital-acquired infections (HAIs) Control Market Size and Forecast by Region
1.6.1 Global Hospital-acquired infections (HAIs) Control Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Hospital-acquired infections (HAIs) Control Market Size by Region, (2019-2030)
1.6.3 North America Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
1.6.4 Europe Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
1.6.6 South America Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Hospital-acquired infections (HAIs) Control Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 STERIS Corporation
2.1.1 STERIS Corporation Details
2.1.2 STERIS Corporation Major Business
2.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Product and Solutions
2.1.4 STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 STERIS Corporation Recent Developments and Future Plans
2.2 Advanced Sterilization Products Division
2.2.1 Advanced Sterilization Products Division Details
2.2.2 Advanced Sterilization Products Division Major Business
2.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product and Solutions
2.2.4 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Advanced Sterilization Products Division Recent Developments and Future Plans
2.3 Hoffmann-La Roche
2.3.1 Hoffmann-La Roche Details
2.3.2 Hoffmann-La Roche Major Business
2.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product and Solutions
2.3.4 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Hoffmann-La Roche Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Hospital-acquired infections (HAIs) Control Product and Solutions
2.4.4 Pfizer Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Becton Dickinson
2.5.1 Becton Dickinson Details
2.5.2 Becton Dickinson Major Business
2.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Product and Solutions
2.5.4 Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Becton Dickinson Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Hospital-acquired infections (HAIs) Control Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Hospital-acquired infections (HAIs) Control by Company Revenue
3.2.2 Top 3 Hospital-acquired infections (HAIs) Control Players Market Share in 2023
3.2.3 Top 6 Hospital-acquired infections (HAIs) Control Players Market Share in 2023
3.3 Hospital-acquired infections (HAIs) Control Market: Overall Company Footprint Analysis
3.3.1 Hospital-acquired infections (HAIs) Control Market: Region Footprint
3.3.2 Hospital-acquired infections (HAIs) Control Market: Company Product Type Footprint
3.3.3 Hospital-acquired infections (HAIs) Control Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Hospital-acquired infections (HAIs) Control Consumption Value and Market Share by Type (2019-2024)
4.2 Global Hospital-acquired infections (HAIs) Control Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2024)
5.2 Global Hospital-acquired infections (HAIs) Control Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
6.2 North America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
6.3 North America Hospital-acquired infections (HAIs) Control Market Size by Country
6.3.1 North America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2030)
6.3.2 United States Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
6.3.3 Canada Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
6.3.4 Mexico Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
7.2 Europe Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
7.3 Europe Hospital-acquired infections (HAIs) Control Market Size by Country
7.3.1 Europe Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2030)
7.3.2 Germany Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7.3.3 France Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7.3.5 Russia Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
7.3.6 Italy Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Region
8.3.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Region (2019-2030)
8.3.2 China Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.3 Japan Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.4 South Korea Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.5 India Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
8.3.7 Australia Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
9.2 South America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
9.3 South America Hospital-acquired infections (HAIs) Control Market Size by Country
9.3.1 South America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2030)
9.3.2 Brazil Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
9.3.3 Argentina Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country
10.3.1 Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2030)
10.3.2 Turkey Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
10.3.4 UAE Hospital-acquired infections (HAIs) Control Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Hospital-acquired infections (HAIs) Control Market Drivers
11.2 Hospital-acquired infections (HAIs) Control Market Restraints
11.3 Hospital-acquired infections (HAIs) Control Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Hospital-acquired infections (HAIs) Control Industry Chain
12.2 Hospital-acquired infections (HAIs) Control Upstream Analysis
12.3 Hospital-acquired infections (HAIs) Control Midstream Analysis
12.4 Hospital-acquired infections (HAIs) Control Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Hospital-acquired infections (HAIs) Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Hospital-acquired infections (HAIs) Control Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Hospital-acquired infections (HAIs) Control Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Hospital-acquired infections (HAIs) Control Consumption Value by Region (2025-2030) & (USD Million)
Table 5. STERIS Corporation Company Information, Head Office, and Major Competitors
Table 6. STERIS Corporation Major Business
Table 7. STERIS Corporation Hospital-acquired infections (HAIs) Control Product and Solutions
Table 8. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. STERIS Corporation Recent Developments and Future Plans
Table 10. Advanced Sterilization Products Division Company Information, Head Office, and Major Competitors
Table 11. Advanced Sterilization Products Division Major Business
Table 12. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product and Solutions
Table 13. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Advanced Sterilization Products Division Recent Developments and Future Plans
Table 15. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 16. Hoffmann-La Roche Major Business
Table 17. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product and Solutions
Table 18. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Hoffmann-La Roche Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Hospital-acquired infections (HAIs) Control Product and Solutions
Table 23. Pfizer Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 26. Becton Dickinson Major Business
Table 27. Becton Dickinson Hospital-acquired infections (HAIs) Control Product and Solutions
Table 28. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Becton Dickinson Recent Developments and Future Plans
Table 30. Global Hospital-acquired infections (HAIs) Control Revenue (USD Million) by Players (2019-2024)
Table 31. Global Hospital-acquired infections (HAIs) Control Revenue Share by Players (2019-2024)
Table 32. Breakdown of Hospital-acquired infections (HAIs) Control by Company Type (Tier 1, Tier 2, and Tier 3)
Table 33. Market Position of Players in Hospital-acquired infections (HAIs) Control, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 34. Head Office of Key Hospital-acquired infections (HAIs) Control Players
Table 35. Hospital-acquired infections (HAIs) Control Market: Company Product Type Footprint
Table 36. Hospital-acquired infections (HAIs) Control Market: Company Product Application Footprint
Table 37. Hospital-acquired infections (HAIs) Control New Market Entrants and Barriers to Market Entry
Table 38. Hospital-acquired infections (HAIs) Control Mergers, Acquisition, Agreements, and Collaborations
Table 39. Global Hospital-acquired infections (HAIs) Control Consumption Value (USD Million) by Type (2019-2024)
Table 40. Global Hospital-acquired infections (HAIs) Control Consumption Value Share by Type (2019-2024)
Table 41. Global Hospital-acquired infections (HAIs) Control Consumption Value Forecast by Type (2025-2030)
Table 42. Global Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024)
Table 43. Global Hospital-acquired infections (HAIs) Control Consumption Value Forecast by Application (2025-2030)
Table 44. North America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 45. North America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 46. North America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 47. North America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 48. North America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2024) & (USD Million)
Table 49. North America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2025-2030) & (USD Million)
Table 50. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 53. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 54. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 57. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 58. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 59. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 60. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Region (2019-2024) & (USD Million)
Table 61. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Region (2025-2030) & (USD Million)
Table 62. South America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 63. South America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 64. South America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 65. South America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 66. South America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2024) & (USD Million)
Table 67. South America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 69. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 70. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 71. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 72. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2024) & (USD Million)
Table 73. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Country (2025-2030) & (USD Million)
Table 74. Hospital-acquired infections (HAIs) Control Raw Material
Table 75. Key Suppliers of Hospital-acquired infections (HAIs) Control Raw Materials
Table 1. Global Hospital-acquired infections (HAIs) Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Hospital-acquired infections (HAIs) Control Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Hospital-acquired infections (HAIs) Control Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Hospital-acquired infections (HAIs) Control Consumption Value by Region (2025-2030) & (USD Million)
Table 5. STERIS Corporation Company Information, Head Office, and Major Competitors
Table 6. STERIS Corporation Major Business
Table 7. STERIS Corporation Hospital-acquired infections (HAIs) Control Product and Solutions
Table 8. STERIS Corporation Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. STERIS Corporation Recent Developments and Future Plans
Table 10. Advanced Sterilization Products Division Company Information, Head Office, and Major Competitors
Table 11. Advanced Sterilization Products Division Major Business
Table 12. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product and Solutions
Table 13. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Advanced Sterilization Products Division Recent Developments and Future Plans
Table 15. Hoffmann-La Roche Company Information, Head Office, and Major Competitors
Table 16. Hoffmann-La Roche Major Business
Table 17. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product and Solutions
Table 18. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Hoffmann-La Roche Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Hospital-acquired infections (HAIs) Control Product and Solutions
Table 23. Pfizer Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Becton Dickinson Company Information, Head Office, and Major Competitors
Table 26. Becton Dickinson Major Business
Table 27. Becton Dickinson Hospital-acquired infections (HAIs) Control Product and Solutions
Table 28. Becton Dickinson Hospital-acquired infections (HAIs) Control Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Becton Dickinson Recent Developments and Future Plans
Table 30. Global Hospital-acquired infections (HAIs) Control Revenue (USD Million) by Players (2019-2024)
Table 31. Global Hospital-acquired infections (HAIs) Control Revenue Share by Players (2019-2024)
Table 32. Breakdown of Hospital-acquired infections (HAIs) Control by Company Type (Tier 1, Tier 2, and Tier 3)
Table 33. Market Position of Players in Hospital-acquired infections (HAIs) Control, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 34. Head Office of Key Hospital-acquired infections (HAIs) Control Players
Table 35. Hospital-acquired infections (HAIs) Control Market: Company Product Type Footprint
Table 36. Hospital-acquired infections (HAIs) Control Market: Company Product Application Footprint
Table 37. Hospital-acquired infections (HAIs) Control New Market Entrants and Barriers to Market Entry
Table 38. Hospital-acquired infections (HAIs) Control Mergers, Acquisition, Agreements, and Collaborations
Table 39. Global Hospital-acquired infections (HAIs) Control Consumption Value (USD Million) by Type (2019-2024)
Table 40. Global Hospital-acquired infections (HAIs) Control Consumption Value Share by Type (2019-2024)
Table 41. Global Hospital-acquired infections (HAIs) Control Consumption Value Forecast by Type (2025-2030)
Table 42. Global Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024)
Table 43. Global Hospital-acquired infections (HAIs) Control Consumption Value Forecast by Application (2025-2030)
Table 44. North America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 45. North America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 46. North America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 47. North America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 48. North America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2024) & (USD Million)
Table 49. North America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2025-2030) & (USD Million)
Table 50. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 51. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 52. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 53. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 54. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Hospital-acquired infections (HAIs) Control Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 57. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 58. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 59. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 60. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Region (2019-2024) & (USD Million)
Table 61. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value by Region (2025-2030) & (USD Million)
Table 62. South America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 63. South America Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 64. South America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 65. South America Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 66. South America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2024) & (USD Million)
Table 67. South America Hospital-acquired infections (HAIs) Control Consumption Value by Country (2025-2030) & (USD Million)
Table 68. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Type (2019-2024) & (USD Million)
Table 69. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Type (2025-2030) & (USD Million)
Table 70. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Application (2019-2024) & (USD Million)
Table 71. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Application (2025-2030) & (USD Million)
Table 72. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Country (2019-2024) & (USD Million)
Table 73. Middle East & Africa Hospital-acquired infections (HAIs) Control Consumption Value by Country (2025-2030) & (USD Million)
Table 74. Hospital-acquired infections (HAIs) Control Raw Material
Table 75. Key Suppliers of Hospital-acquired infections (HAIs) Control Raw Materials
LIST OF FIGURES
Figure 1. Hospital-acquired infections (HAIs) Control Picture
Figure 2. Global Hospital-acquired infections (HAIs) Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type in 2023
Figure 4. Diagnostic techniques
Figure 5. Dleaning and sterilization
Figure 6. Treatment
Figure 7. Global Hospital-acquired infections (HAIs) Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application in 2023
Figure 9. General Hospital Picture
Figure 10. Infectious Disease Hospital Picture
Figure 11. Global Hospital-acquired infections (HAIs) Control Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Hospital-acquired infections (HAIs) Control Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Hospital-acquired infections (HAIs) Control Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Region in 2023
Figure 16. North America Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Hospital-acquired infections (HAIs) Control Revenue Share by Players in 2023
Figure 22. Hospital-acquired infections (HAIs) Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Hospital-acquired infections (HAIs) Control Market Share in 2023
Figure 24. Global Top 6 Players Hospital-acquired infections (HAIs) Control Market Share in 2023
Figure 25. Global Hospital-acquired infections (HAIs) Control Consumption Value Share by Type (2019-2024)
Figure 26. Global Hospital-acquired infections (HAIs) Control Market Share Forecast by Type (2025-2030)
Figure 27. Global Hospital-acquired infections (HAIs) Control Consumption Value Share by Application (2019-2024)
Figure 28. Global Hospital-acquired infections (HAIs) Control Market Share Forecast by Application (2025-2030)
Figure 29. North America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 39. France Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Region (2019-2030)
Figure 46. China Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 49. India Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 63. Hospital-acquired infections (HAIs) Control Market Drivers
Figure 64. Hospital-acquired infections (HAIs) Control Market Restraints
Figure 65. Hospital-acquired infections (HAIs) Control Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Hospital-acquired infections (HAIs) Control in 2023
Figure 68. Manufacturing Process Analysis of Hospital-acquired infections (HAIs) Control
Figure 69. Hospital-acquired infections (HAIs) Control Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Hospital-acquired infections (HAIs) Control Picture
Figure 2. Global Hospital-acquired infections (HAIs) Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type in 2023
Figure 4. Diagnostic techniques
Figure 5. Dleaning and sterilization
Figure 6. Treatment
Figure 7. Global Hospital-acquired infections (HAIs) Control Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application in 2023
Figure 9. General Hospital Picture
Figure 10. Infectious Disease Hospital Picture
Figure 11. Global Hospital-acquired infections (HAIs) Control Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Hospital-acquired infections (HAIs) Control Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Hospital-acquired infections (HAIs) Control Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Region in 2023
Figure 16. North America Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Hospital-acquired infections (HAIs) Control Revenue Share by Players in 2023
Figure 22. Hospital-acquired infections (HAIs) Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Hospital-acquired infections (HAIs) Control Market Share in 2023
Figure 24. Global Top 6 Players Hospital-acquired infections (HAIs) Control Market Share in 2023
Figure 25. Global Hospital-acquired infections (HAIs) Control Consumption Value Share by Type (2019-2024)
Figure 26. Global Hospital-acquired infections (HAIs) Control Market Share Forecast by Type (2025-2030)
Figure 27. Global Hospital-acquired infections (HAIs) Control Consumption Value Share by Application (2019-2024)
Figure 28. Global Hospital-acquired infections (HAIs) Control Market Share Forecast by Application (2025-2030)
Figure 29. North America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 39. France Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Region (2019-2030)
Figure 46. China Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 49. India Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Hospital-acquired infections (HAIs) Control Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Hospital-acquired infections (HAIs) Control Consumption Value (2019-2030) & (USD Million)
Figure 63. Hospital-acquired infections (HAIs) Control Market Drivers
Figure 64. Hospital-acquired infections (HAIs) Control Market Restraints
Figure 65. Hospital-acquired infections (HAIs) Control Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Hospital-acquired infections (HAIs) Control in 2023
Figure 68. Manufacturing Process Analysis of Hospital-acquired infections (HAIs) Control
Figure 69. Hospital-acquired infections (HAIs) Control Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
More Publications
Global Safety Data Sheet (SDS) Management Market 2022 by Company, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
July 2022
89 pages
Global Cased Hole Logging Services Market 2024 by Company, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
June 2024
111 pages
Global Furniture Store POS Software Market 2024 by Company, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
August 2024
127 pages
Global Decision-making Software Market 2024 by Company, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
August 2024
125 pages
Global Property & Casualty Insurance Agency Management Software Market 2022 by Company, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
August 2022
86 pages
